Expert Review on Poliovirus Immunity and Transmission
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Successfully managing risks to achieve wild polioviruses (WPVs) eradication and address the complexities of oral poliovirus vaccine (OPV) cessation to stop all cases of paralytic poliomyelitis depends strongly on our collective understanding of poliovirus immunity and transmission. With increased shifting from OPV to inactivated poliovirus vaccine (IPV), numerous risk management choices motivate the need to understand the tradeoffs and uncertainties and to develop models to help inform decisions. The U.S. Centers for Disease Control and Prevention hosted a meeting of international experts in April 2010 to review the available literature relevant to poliovirus immunity and transmission. This expert review evaluates 66 OPV challenge studies and other evidence to support the development of quantitative models of poliovirus transmission and potential outbreaks. This review focuses on characterization of immunity as a function of exposure history in terms of susceptibility to excretion, duration of excretion, and concentration of excreted virus. We also discuss the evidence of waning of host immunity to poliovirus transmission, the relationship between the concentration of poliovirus excreted and infectiousness, the importance of different transmission routes, and the differences in transmissibility between OPV and WPV. We discuss the limitations of the available evidence for use in polio risk models, and conclude that despite the relatively large number of studies on immunity, very limited data exist to directly support quantification of model inputs related to transmission. Given the limitations in the evidence, we identify the need for expert input to derive quantitative model inputs from the existing data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review.
Patriarca, P. A., Wright, P. F., & John, T. J. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.5.926 · Cited by 453
Self-citationFine, P. E. M., & Carneiro, I. A. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009924 · Cited by 247
Alexander, J. P., Gary, H. E., & Pallansch, M. A. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s176 · Cited by 170 · cited 2×
“In addition, we identified 42 OPV challenge studies previously known by the authors, published after March 2010, or cited in other OPV challenge studies or reviews on poliovirus immunity.(14,15,34) In addition to the OPV challenge studies, numerous studies exist that provide results from stool sampling in the context…”
Self-citationHerremans, T. M. P. T., Reimerink, J. H. J., Buisman, A. M., Kimman, T. G., & Koopmans, M. P. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.5011 · Cited by 149
Inactivated poliovirus vaccine: Past and present experience
Murdin, A. D., Barreto, L., & Plotkin, S. (1996) · Vaccine · doi:10.1016/0264-410x(95)00211-i · Cited by 135 · cited 3×
“(14,15) Given the known effect of additional doses on serum antibody titers,(14,33,100) the correlation between antibody titer and excretion represents a key relationship that affects characterization of differences within the IPV and the LPV immunity states.”
Henry, J. L., Jaikaran, E. S., Davies, J. R., Tomlinson, A. J. H., Mason, P. J., Barnes, J. M., & Beale, A. J. (1966) · Journal of Hygiene · doi:10.1017/s0022172400040389 · Cited by 101 · cited 12×
“Grading Table of the Evidence for the Relative Susceptibility to Poliovirus Excretion from OPV Challenge Studies Recent Immunity Number of Included Overall State Studies(refs)a Design Relevance Quality Consistency Grade Maternally immune 3(43,50,55) High Moderate Moderate High Moderate 1 successful IPV dose 1(57,59) L…”
MethodInfluentialBENYESH-MELNICK, M., MELNICK, J. L., RAWLS, W. E., WIMBERLY, I., ORO, J. B., BEN-PORATH, E., & RENNICK, V. (1967) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120717 · Cited by 93 · cited 6×
“Two studies(19,53) that include separate challenge arms for each serotype found no notable difference in the probability of excretion over time (Fig.”
InfluentialRandomized, Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa054960 · Cited by 90
Cited by
Polio vaccination: Past, present and future
Bandyopadhyay, A. S., Garon, J., Seib, K., & Orenstein, W. A. (2015) · Future Microbiology · doi:10.2217/fmb.15.19 · Cited by 276
Duintjer Tebbens, R. J., & Thompson, K. M. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit838 · Cited by 48
Self-citationCSF in acute and chronic infectious diseases
(2018) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804279-3.00012-5 · Cited by 42
Metadata
- Authors
- Duintjer Tebbens, R. J., Pallansch, M. A., Chumakov, K. M., Halsey, N. A., Hovi, T., Minor, P. D., Modlin, J. F., Patriarca, P. A., Sutter, R. W., Wright, P. F., Wassilak, S. G. F., Cochi, S. L., Kim, J., & Thompson, K. M.
- Venue
- Risk Analysis
- Publisher
- Wiley
- Published
- 2012-07-15
- Volume
- 33
- Issue
- 4
- Pages
- 544-605
- ISSN
- 0272-4332 (ISSN-L)
- 1539-6924
- OpenAlex
- W2149302911
- Cited by
- 109
- References
- 14
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expert Review on Poliovirus Immunity and Transmission. https://app.cochat.ai/papers/10.1111/j.1539-6924.2012.01864.x
- The paper
- Duintjer Tebbens, R. J., Pallansch, M. A., Chumakov, K. M., Halsey, N. A., Hovi, T., Minor, P. D., Modlin, J. F., Patriarca, P. A., Sutter, R. W., Wright, P. F., Wassilak, S. G. F., Cochi, S. L., Kim, J., & Thompson, K. M. (2013). Expert Review on Poliovirus Immunity and Transmission. Risk Analysis. https://doi.org/10.1111/j.1539-6924.2012.01864.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.